Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
83%(5 trials)

Phase Distribution

Ph phase_4
4
44%
Ph not_applicable
1
11%
Ph phase_3
4
44%

Phase Distribution

0

Early Stage

0

Mid Stage

8

Late Stage

Phase Distribution9 total trials
Phase 3Large-scale testing
4(44.4%)
Phase 4Post-market surveillance
4(44.4%)
N/ANon-phased studies
1(11.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Active(1)
Completed(6)
Other(2)

Detailed Status

Completed6
unknown2
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 34 (44.4%)
Phase 44 (44.4%)
N/A1 (11.1%)

Trials by Status

enrolling_by_invitation111%
completed667%
unknown222%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
9